Cargando…

Neuroblastoma versus systemic JIA – a diagnostic dilemma

Detalles Bibliográficos
Autores principales:	Scalzi, Lisabeth, Hychko, Greg, Ostrov, Barbara E, Bingham, Catherine A, Ungar, David, Groh, Brandt P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403160/ http://dx.doi.org/10.1186/1546-0096-10-S1-A33

Ejemplares similares

Med-peds rheumatology in practice: assessment after twenty years
por: Ostrov, Barbara E, et al.
Publicado: (2012)

An assessment of variables affecting transition readiness in pediatric rheumatology patients
por: Bingham, Catherine April, et al.
Publicado: (2015)

Patient preferences and satisfaction in a multispecialty infusion center
por: Ostrov, Barbara E, et al.
Publicado: (2014)

MEFV mutations in systemic JIA
por: Aktay Ayaz, N, et al.
Publicado: (2008)

Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry
por: Hahn, Timothy, et al.
Publicado: (2022)

Correction: Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry
por: Hahn, Timothy, et al.
Publicado: (2022)

Determing an “autoimmune” phenotype in systemic JIA
por: Fischer, N, et al.
Publicado: (2011)

Mesenchymal stem cells and JIA
por: Swart, JF, et al.
Publicado: (2011)

The swedish paediatric JIA-registry
por: Magnusson, Bo
Publicado: (2014)

Puberty and disease activity in JIA
por: Van Pelt, Philomine, et al.
Publicado: (2014)

Clinical classification of JIA in Albania
por: Vula, Aurel, et al.
Publicado: (2014)

Are genetic variants of Caspase-1 and Cryopyrin associated with systemic JIA?
por: Stock, CJ, et al.
Publicado: (2008)

The efficacy and safety of Tocilizumab in adults with refractory systemic onset JIA
por: Deslypere, G, et al.
Publicado: (2011)

PReS-FINAL-2254: Is it systemic JIA or post infectious illness?
por: Guddeti, P, et al.
Publicado: (2013)

PReS-FINAL-2246: CBCT versus orthopan tomogram detecting TMJ alteration in JIA
por: Arvonen, P, et al.
Publicado: (2013)

Adverse events of methotrexate treatment in JIA
por: in ‘t Veld, J, et al.
Publicado: (2011)

Evaluation of the JIA treatment with adalimumab in ukraine
por: Ponochevna, Elena, et al.
Publicado: (2014)

Effect of ANA positivity on clinical picture of the JIA: should ANA positive JIA be classified as a different group?
por: Polat, Adem, et al.
Publicado: (2011)

PReS-FINAL-2057: Systemic onset JIA with coronary artery dilatation
por: Aktay Ayaz, N, et al.
Publicado: (2013)

Demographic, clinical and treatment characteristics of the carra registry systemic JIA cohort
por: Janow, Ginger, et al.
Publicado: (2014)

PReS-FINAL-2102: Comparison of sensitivity and specificity of MAS and HLH diagnostic guidelines in 362 children with MAS complicating systemic JIA
por: Davì, S, et al.
Publicado: (2013)

Autoimmune hepatitis or systemic lupus erythematosus? A diagnostic dilemma
por: Makay, B, et al.
Publicado: (2008)

Ocular threat in juvenile idiopathic arthritis (JIA)
por: Marvillet, I, et al.
Publicado: (2008)

Use of internet in adolescents and young adults with JIA
por: Van Pelt, Philomine, et al.
Publicado: (2014)

JIA-like in a boy with Ataxia-telangiectasia
por: Furtado, Filipa, et al.
Publicado: (2014)

Understanding the biology and use of TNF therapy in jia-clinical outcomes
por: Lovell, Daniel, et al.
Publicado: (2014)

PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients
por: Lu, P, et al.
Publicado: (2013)

Accuracy of preliminary remission criteria some JIA category
por: Fantini, F, et al.
Publicado: (2008)

Mandibular condyle destruction in juvenile idiopathic arthritis (JIA)
por: Zak, M, et al.
Publicado: (2008)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
por: Pontikaki, I, et al.
Publicado: (2008)

Tocilizumab for the treatment of systemic onset JIA: a single centre experience from India
por: Sawhney, Sujata, et al.
Publicado: (2012)

PReS-FINAL-2038: Clinical efficacy and tolerability of tocilizumab in patients with persistant systemic JIA
por: Mihailova, D, et al.
Publicado: (2013)

The correlation between clinical and ultrasonographic findings of ankle disease in JIA
por: Burns, JFT, et al.
Publicado: (2008)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
por: Bracaglia, C, et al.
Publicado: (2008)

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA)
por: Alpigiani, MG, et al.
Publicado: (2008)

Changes in articular cartilage thickness of the knee in JIA as assessed by ultrasonography
por: Pradsgaard, D, et al.
Publicado: (2011)

Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?
por: Officioso, A, et al.
Publicado: (2011)

Evaluation of disease activity in a population of Russian JIA patients
por: Kostareva, OM, et al.
Publicado: (2011)

Sport and exercise habits in children with juvenile idiopathic arthritis (JIA)
por: Nørgaard, M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_i9q14t1ujsm3c4glo1sgdt421b